Raymond James & Associates’s Milestone Scientific MLSS Stock Holding History

Raymond James & Associates’s Portfolio MLSS Stock Details MLSS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	$10.9K	Hold	12,000	–	–	﹤0.01%	3966
2024 Q2	$8.2K	Hold	12,000	–	–	﹤0.01%	3934
2024 Q1	$7.48K	Hold	12,000	–	–	﹤0.01%	3905
2023 Q4	$8.28K	Hold	12,000	–	–	﹤0.01%	3805
2023 Q3	$11K	Sell	12,000 -8,000	-40%	-$8.42K	﹤0.01%	3758
2023 Q2	$17.4K	Hold	20,000	–	–	﹤0.01%	3781
2023 Q1	$18K	Hold	20,000	–	–	﹤0.01%	3805
2022 Q4	$9.6K	Hold	20,000	–	–	﹤0.01%	3850
2022 Q3	$16K	Hold	20,000	–	–	﹤0.01%	3812
2022 Q2	$18K	Hold	20,000	–	–	﹤0.01%	3884
2022 Q1	$30K	Hold	20,000	–	–	﹤0.01%	3962
2021 Q4	$41K	Buy	20,000 +4,000	+25%	+$8.8K	﹤0.01%	3971
2021 Q3	$30K	Hold	16,000	–	–	﹤0.01%	3965
2021 Q2	$39K	Buy	+16,000	New	+$38.8K	﹤0.01%	3935

Other funds holding MLSS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

CIC

Carnegie Investment Counsel Pepper Pike, Ohio $5.13B AUM 22.98% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIA

World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Raymond James & Associates's MLSS Position: Q3 2024 in Review

Raymond James & Associates held its Milestone Scientific (MLSS) position steady in Q3 2024 at 12,000 shares worth $10.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3966.

Raymond James & Associates first reported a position in MLSS in Q2 2021 and has held it in 14 quarters since. The position peaked at $41K in Q4 2021. 36 funds tracked by Wall St. Rank hold MLSS as of Q3 2024.

Raymond James & Associates held 12,000 shares of Milestone Scientific worth $10.9K as of Q3 2024.
Raymond James & Associates left its Milestone Scientific share count unchanged in Q3 2024.
Milestone Scientific made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3966 holding.
Raymond James & Associates first reported a position in Milestone Scientific in Q2 2021 and has held it in 14 quarters since.
Raymond James & Associates's Milestone Scientific position peaked at $41K in Q4 2021.
36 funds tracked by Wall St. Rank held Milestone Scientific as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.